These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G. Cancer; 1994 Oct 01; 74(7):1874-81. PubMed ID: 8082093 [Abstract] [Full Text] [Related]
3. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W. Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129 [Abstract] [Full Text] [Related]
4. Phase I-II trial of concomitant continuous carboplatin (CBDCA) infusion and radiotherapy in advanced nonsmall cell lung cancer with evaluation for surgery: final report. Trodella L, Cellini N, Picciocchi A, Marano P, Balducci M, Mantini G, Turriziani A, Corbo GM, Valente S, Valentini V, Pirronti T, Granone P, Dobelbower RR. Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):93-101. PubMed ID: 9054882 [Abstract] [Full Text] [Related]
5. Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC). Kaplan B, Altýnbas M, Eroglu C, Karahacioglu E, Er O, Ozkan M, Bilgin M, Canoz O, Gulmez I, Gulec M. Am J Clin Oncol; 2004 Dec 01; 27(6):603-10. PubMed ID: 15577439 [Abstract] [Full Text] [Related]
6. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma. Pignon T, Ruggieri S, Boutin C, Gouvernet J, Irisson M, Juin P, Astoul P. Cancer; 1999 May 15; 85(10):2144-50. PubMed ID: 10326692 [Abstract] [Full Text] [Related]
7. A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer. Jeremic B, Shibamoto Y, Milicic B, Milisavljevic S, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G. Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):343-8. PubMed ID: 10760429 [Abstract] [Full Text] [Related]
14. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. J Clin Oncol; 2001 Jan 15; 19(2):442-7. PubMed ID: 11208837 [Abstract] [Full Text] [Related]